Table of Contents
This report analyzes the Global Market for Small Molecule Kinase Inhibitors in Millions of US$ by the following Product Segments: Gleevec/Glivec, Tarceva, Sutent, Nexavar, Sprycel, Iressa, Tykerb/Tyverb, and Others. Annual forecasts are provided for the period 2006 through 2015. The report profiles 83 companies including many key and niche players worldwide such as Amgen, Inc., Asahi Kasei Pharma Corporation, AstraZeneca plc., Bayer Schering Ph...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Robyn
+1 718 213 4904
"Analytical Tool - Hematological Cancers" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in hematological cancers. It is ...
Market Opportunities for Differentiated Therapeutics Type 2 diabetes is one of the most significant global health concerns of modern times. The size of the diabetes therapeutics market has stimulated a ...
What Pharmaceutical and Biotechnology Companies Want and How to Compete for their Business The overall objective of this study was to provide contract manufacturing organizations (CMOs) a sound basis fo ...
... Treatments, pipelines, and commercial opportunities, spectra intelligence, april 2006, pages: 369 2--melanoma therapeutics - pipeline assessment and market forecasts to 2019, globaldata 3--american cancer ...
... Increased demands on the system in a way that puts business as usual at risk. Diseases vaccinated against vaccine volume per fully immunized child (cm3) immunization cost per child ($) (including ...
Company Profiles10 Companies
Reportlinker.com © Copyright 2013. All rights reserved.